Adina Olaru
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Adina Olaru has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
Ayman Jafer
Department of Medical Laboratory Sciences, Faculty of Applied Medical Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia
1 shared publication- Dhanny Gomez
Nottingham University Hospitals NHS Trust, Nottingham, UK
1 shared publication - Edward Alabraba
Nottingham University Hospitals, NHS Trust, Nottingham, United Kingdom
1 shared publication - Gordon William Moran
NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and the University of Nottingham, Nottingham, UK
1 shared publication - Hala Fatani
Translational Medical Sciences, Nottingham Digestive Diseases Centre, School of Medicine, University of Nottingham, Nottingham NG7 2UH, UK
1 shared publication - Hussain Ibrahim
University of Nottingham, Faculty of Medicine and Health Sciences, Medical School, Queen's Medical Center, Nottingham NG7 2UH, England
1 shared publication
Latest Publications
- Top Cited PapersOpen Access
- 2 June 2023
- Published by Elsevier in Clinical Nutrition
- Vol. 42 (8) , 1276-1291
Systematic review of sarcopenia in inflammatory bowel disease
- 2 June 2023
- Published by Elsevier in Clinical Nutrition
- Vol. 42 (8) , 1276-1291
Top Cited PapersOpen AccessSystematic review of sarcopenia in inflammatory bowel disease
- Open Access
- 1 February 2023
- Published by Oxford University Press (OUP) in Oxford Medical Case Reports
- Vol. 2023 (2) , 69-71
A case of idiopathic chylous ascites
Chylous ascites is a rare condition found in 1 in 20 000 patients admitted to hospital with abdominal distention. It is caused by a limited number of pathologies but can, in rare situations, be idiopathic. Its management is difficult and usually involves correcting the primary pathology, making idiopathic chylous ascites particularly difficult to manage. We present a case of idiopathic chylous ascites extensively investigated over a period of several years. An incidental finding of B cell lymphoma was initially suspected to have been the primary cause of the ascites; however, after successful treatment of this condition, the patient’s ascites did not resolve. Diagnostic difficulties and management are discussed and an overview of the diagnostic process is outlined through this case.
- 1 February 2023
- Published by Oxford University Press (OUP) in Oxford Medical Case Reports
- Vol. 2023 (2) , 69-71
Open AccessA case of idiopathic chylous ascites
Chylous ascites is a rare condition found in 1 in 20 000 patients admitted to hospital with abdominal distention. It is caused by a limited number of pathologies but can, in rare situations, be idiopathic. Its management is difficult and usually involves correcting the primary pathology, making idiopathic chylous ascites particularly difficult to manage. We present a case of idiopathic chylous ascites extensively investigated over a period of several years. An incidental finding of B cell lymphoma was initially suspected to have been the primary cause of the ascites; however, after successful treatment of this condition, the patient’s ascites did not resolve. Diagnostic difficulties and management are discussed and an overview of the diagnostic process is outlined through this case.
- 18 December 2019
- Published by Springer Nature in Journal of Gastrointestinal Cancer
- Vol. 52 (1) , 106-112
ACE Inhibitor Therapy Does Not Influence the Survival Outcomes of Patients with Colorectal Liver Metastases Following Liver Resection
Angiotensin-converting enzyme (ACE) inhibitors have been shown to possibly influence the survival outcomes in certain cancers. The aim of this study was to evaluate the impact of ACE inhibitors on the outcomes of patients undergoing liver resection for colorectal liver metastases (CRLM). The secondary aim was to determine whether ACE inhibitors influenced histopathological changes in CRLM.
- 18 December 2019
- Published by Springer Nature in Journal of Gastrointestinal Cancer
- Vol. 52 (1) , 106-112
ACE Inhibitor Therapy Does Not Influence the Survival Outcomes of Patients with Colorectal Liver Metastases Following Liver Resection
Angiotensin-converting enzyme (ACE) inhibitors have been shown to possibly influence the survival outcomes in certain cancers. The aim of this study was to evaluate the impact of ACE inhibitors on the outcomes of patients undergoing liver resection for colorectal liver metastases (CRLM). The secondary aim was to determine whether ACE inhibitors influenced histopathological changes in CRLM.